We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV.
- Authors
Marchitto, Lorie; Chatterjee, Debashree; Ding, Shilei; Gendron-Lepage, Gabrielle; Tauzin, Alexandra; Boutin, Marianne; Benlarbi, Mehdi; Medjahed, Halima; Sylla, Mohamed; Lanctôt, Hélène; Durand, Madeleine; Finzi, Andrés; Tremblay, Cécile
- Abstract
While mRNA SARS-CoV-2 vaccination elicits strong humoral responses in the general population, humoral responses in people living with HIV (PLWH) remain to be clarified. Here, we conducted a longitudinal study of vaccine immunogenicity elicited after two and three doses of mRNA SARS-CoV-2 vaccine in PLWH stratified by their CD4 count. We measured the capacity of the antibodies elicited by vaccination to bind the Spike glycoprotein of different variants of concern (VOCs). We also evaluated the Fc-mediated effector functions of these antibodies by measuring their ability to eliminate CEM.NKr cells stably expressing SARS-CoV-2 Spikes. Finally, we measured the relative capacity of the antibodies to neutralize authentic SARS-CoV-2 virus after the third dose of mRNA vaccine. We found that after two doses of SARS-CoV-2 mRNA vaccine, PLWH with a CD4 count < 250/mm3 had lower levels of anti-RBD IgG antibodies compared to PLWH with a CD4 count > 250/mm3 (p < 0.05). A third dose increased these levels and importantly, no major differences were observed in their capacity to mediate Fc-effector functions and neutralize authentic SARS-CoV-2. Overall, our work demonstrates the importance of mRNA vaccine boosting in immuno-compromised individuals presenting low levels of CD4.
- Subjects
COVID-19 vaccines; HIV-positive persons; VACCINE immunogenicity; FC receptors; IMMUNE response; IMMUNOGLOBULINS; CD4 lymphocyte count
- Publication
Viruses (1999-4915), 2023, Vol 15, Issue 10, p2004
- ISSN
1999-4915
- Publication type
Article
- DOI
10.3390/v15102004